INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
← Government Money

REGENERON PHARMACEUTICALS INC

IGF::OT::IGF

USAspending award recordLast modified Sep 25, 2026 · verified Nov 10, 2026
  1. 01AgencyDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
  2. 02AwardHHSO100201700016CDEFINITIVE CONTRACT
  3. 03RecipientREGENERON PHARMACEUTICALS INCNY
  4. 04ParentREGENERON PHARMACEUTICALS INCSAM-reported parent
  5. 05SecurityREGNCurated subsidiary map
Obligated$973.56MCommitted by the government. Not cash paid.
Outlays$239.03MCash paid out so far.
Ceiling$1.04BBase plus all options. A maximum, not a payment.
Period of performanceSep 30, 2017 – Sep 29, 2031

Obligation timeline

Actions and modifications
  1. Sep 25, 2026INMAZEB EBOLA THERAPEUTICS$277.82MMod P00018 · cumulative $277.82M

Record

Award ID
HHSO100201700016C
Category
contract
Industry (NAICS)
541711 · Research and Development in Biotechnology
Product/service (PSC)
AN13
Place of performance
NY
Signed
Sep 28, 2017
Ingested
Nov 4, 2026
Company match
Curated subsidiary map · confidence 0.9